281 related articles for article (PubMed ID: 17695464)
41. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer.
Sanchiz F; Milla A
Jpn J Clin Oncol; 1994 Dec; 24(6):322-6. PubMed ID: 7830337
[TBL] [Abstract][Full Text] [Related]
42. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Pudełko M; Kryj M; Oledzki J; Szmeja J; Słuszniak J; Serkies K; Kładny J; Pamucka M; Kukołowicz P
Radiother Oncol; 2004 Jul; 72(1):15-24. PubMed ID: 15236870
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant therapy of rectal cancer using oral tegaful-uracil (UFT) plus concomitant radiotherapy--a case report.
Yamaguchi Y; Ohshita A; Hironaka K; Emi M; Kawabuchi Y; Sakatani A; Arihiro K
Hiroshima J Med Sci; 2005 Sep; 54(3):87-91. PubMed ID: 16180702
[TBL] [Abstract][Full Text] [Related]
44. [Progress in adjuvant therapy for colorectal cancer].
Kohnoe S; Kakeji Y; Maehara Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
[TBL] [Abstract][Full Text] [Related]
45. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
47. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
[TBL] [Abstract][Full Text] [Related]
48. [A case of long-term survival after resection of advanced undifferentiated rectal cancer treated by short-term preoperative chemoradiotherapy and postoperative adjuvant chemotherapy].
Naito Y; Hashiguchi Y; Ueno H; Kajiwara Y; Shimazaki H; Mochizuki H; Hase K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):117-20. PubMed ID: 21368471
[TBL] [Abstract][Full Text] [Related]
49. Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.
Rosenthal DI; Haller DG; Saltz L; Semple D; Minsky BD
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):59-62. PubMed ID: 11098496
[TBL] [Abstract][Full Text] [Related]
50. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
Gambacorta MA; Valentini V; Coco C; Morganti AG; Smaniotto D; Miccichè F; Mantini G; Barbaro B; Garcia-Vargas JE; Magistrelli P; Picciocchi A; Cellini N
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):139-48. PubMed ID: 15337549
[TBL] [Abstract][Full Text] [Related]
51. [Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Sato Y; Inaba Y; Yamaura H; Shimamoto H; Nishiofuku H; Oyama T; Kanemitsu Y; Sawaki A; Arai Y; Muro K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):887-90. PubMed ID: 16835473
[TBL] [Abstract][Full Text] [Related]
52. Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency.
Lim JF; Tjandra JJ; Hiscock R; Chao MW; Gibbs P
Dis Colon Rectum; 2006 Jan; 49(1):12-9. PubMed ID: 16292664
[TBL] [Abstract][Full Text] [Related]
53. [A case of rectal cancer combined with intraperitoneal abscess responding completely to uracil/tegafur (UFT) plus oral leucovorin (LV) therapy].
Yamada K; Narabashi K; Onoda K; Honda A; Hojyo K; Kawashima H; Hamaya M; Okamoto N; Noda S; Kaneko H; Yokote K
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1587-90. PubMed ID: 20716893
[TBL] [Abstract][Full Text] [Related]
54. [A case of synchronous multiple liver metastases of rectal cancer successfully treated with tegafur/uracil and oral leucovorin chemotherapy].
Ueda S; Minami Y; Hara Y; Kawano T; Tominaga T
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1709-11. PubMed ID: 21996973
[TBL] [Abstract][Full Text] [Related]
55. Role of neo-adjuvant chemoradiation in locally advanced rectal cancers.
Rashid A; Ahmed S; Ali M; Fareed M; Bilal M
J Coll Physicians Surg Pak; 2010 Mar; 20(3):175-80. PubMed ID: 20392380
[TBL] [Abstract][Full Text] [Related]
56. A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer.
Hoff PM; Saad ED; Janjan N; Skibber J; Pazdur R
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):56-8. PubMed ID: 11098495
[TBL] [Abstract][Full Text] [Related]
57. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
59. Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
Wang LW; Hsiao CF; Chen WT; Lee HH; Lin TC; Chen HC; Chen HH; Chien CR; Lin TY; Liu TW
J Surg Oncol; 2014 May; 109(6):580-5. PubMed ID: 24374744
[TBL] [Abstract][Full Text] [Related]
60. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
